November 8-9, 2018: Dr. Leyer Introduces Weight Management Strain, BNR17™ at SSW 2018
BNR17™: A Clinically Supported Weight Management Probiotic
When: Thursday, November 8th, 2:00 – 2:40 PM
Where: Probiotic Resource Theater
Speaker: Chief Scientific Officer of UAS Labs, Dr. Gregory Leyer, PhD
Description: With obesity rates on the rise we are seeing a consumer shift toward healthy lifestyles. From wholesome food to supplements, consumers are looking for effective approaches to weight management. Probiotics fit into this holistic approach to health and clinically-validated products are starting to fill a gap in the market. Understanding the market need, UAS Labs is proud to offer weight management solution Lactobacillus gasseri BNR17. This probiotic strain, derived from human breastmilk, has been through extensive preclinical analysis and three clinical trials. Through research BNR17 has been shown to lessen body mass index, reduce visceral fat and help decrease waist and hip circumference. It is also shown to provide digestive support with improved quality of life scores and normalized gut transit.
Join UAS Labs’ Chief Scientific Officer, Dr. Gregory Leyer, as he discussed the clinical documentation supporting this award willing strain.